<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00818077</url>
  </required_header>
  <id_info>
    <org_study_id>03654-07-A</org_study_id>
    <nct_id>NCT00818077</nct_id>
  </id_info>
  <brief_title>Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food</brief_title>
  <official_title>Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HealthPartners Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Diabetes Center at Park Nicollet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott Diabetes Care</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>HealthPartners Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will look at the impact that meals have on blood glucose (sugar) levels. Subjects&#xD;
      will be asked to use a Continuous Glucose Monitoring System (CGM), which monitors glucose&#xD;
      levels continuously. Breakfast and lunch meals will be provided and must be consumed at the&#xD;
      International Diabetes Center.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic Response to the Fixed Meal</measure>
    <time_frame>4 hour meal test</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Currently Taking Metformin</condition>
  <arm_group>
    <arm_group_label>Metformin, Type 2 Diabetes</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Continuous Glucose Monitoring of Carbohydrate Intake</intervention_name>
    <description>Subjects eat standard breakfast and lunch and keep food records.</description>
    <arm_group_label>Metformin, Type 2 Diabetes</arm_group_label>
    <other_name>Navigator CGM System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        type 2 diabetes, 18 years of age of older, currently taking metformin&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female or male&#xD;
&#xD;
          -  Age 18 and older&#xD;
&#xD;
          -  Diagnosed with type 2 diabetes for a minimum of 6 months&#xD;
&#xD;
          -  Is taking metformin for diabetes management; no other diabetes medications&#xD;
&#xD;
          -  Has been on a stable dose of metformin for at least 3 months&#xD;
&#xD;
          -  HbA1c is 7% or greater and less than 9%; &gt;7% or &lt;9%&#xD;
&#xD;
          -  BMI &lt;30kg/m2&#xD;
&#xD;
          -  Willing to give informed consent&#xD;
&#xD;
          -  No evidence of acute illness, fever, undue stress&#xD;
&#xD;
          -  Motivated and capable of following the protocol and instructions provided by the&#xD;
             healthcare professional&#xD;
&#xD;
          -  Available for the study on the scheduled visit days&#xD;
&#xD;
          -  Access to telephone communications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years of age&#xD;
&#xD;
          -  Has not been diagnosed with type 2 diabetes for a minimum of 6 months&#xD;
&#xD;
          -  Is currently taking other diabetes medications in addition to metformin&#xD;
&#xD;
          -  Has taken other diabetes medications within the past 3 months&#xD;
&#xD;
          -  HbA1c &lt;7% or &gt;9%&#xD;
&#xD;
          -  BMI &gt; 30kg/m2&#xD;
&#xD;
          -  Unable to follow the study protocol&#xD;
&#xD;
          -  No access to telephone communications&#xD;
&#xD;
          -  Unable to read and write in English&#xD;
&#xD;
          -  Unable to maintain their health, or have undue stress&#xD;
&#xD;
          -  Skin abnormalities at the insertion sites that would confound assessment of the effect&#xD;
             of the device on the skin&#xD;
&#xD;
          -  Allergy to adhesives&#xD;
&#xD;
          -  Any concomitant medical condition that would likely affect the evaluation of device&#xD;
             performance&#xD;
&#xD;
          -  Taken oral or inhaled prednisone or cortisone medications in the previous 30 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret Powers, PhD, RD, CDE</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Diabetes Center at Park Nicollet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International Diabetes Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>American Diabetes Association. Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2007 Jan;30 Suppl 1:S48-65.</citation>
    <PMID>17192379</PMID>
  </reference>
  <reference>
    <citation>Franz MJ, Boucher JL, Green-Pastors J, Powers MA. Evidence-based nutrition practice guidelines for diabetes and scope and standards of practice. J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S52-8. doi: 10.1016/j.jada.2008.01.021. Review.</citation>
    <PMID>18358257</PMID>
  </reference>
  <reference>
    <citation>Crapo PA, Reaven G, Olefsky J. Postprandial plasma-glucose and -insulin responses to different complex carbohydrates. Diabetes. 1977 Dec;26(12):1178-83.</citation>
    <PMID>590639</PMID>
  </reference>
  <verification_date>August 2013</verification_date>
  <study_first_submitted>January 5, 2009</study_first_submitted>
  <study_first_submitted_qc>January 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2009</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

